NYSE:UNHHealthcare
UnitedHealth Faces Medicare Scrutiny As Margin Focus Meets Revenue Headwinds
UnitedHealth Group (NYSE:UNH) is under heightened regulatory scrutiny over Medicare Advantage payment practices following a Senate Finance Committee report.
The company is shifting its focus to margin instead of growth as it responds to a tougher reimbursement backdrop and closer oversight.
Management is guiding for the first annual revenue decline in decades, citing adverse Medicare policy proposals.
UnitedHealth Group sits at the center of US managed care, with Medicare Advantage a key...